Sittner & Nelson’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $274K | Buy |
615
+17
| +3% | +$7.57K | 0.11% | 120 |
|
|
2025
Q1 | $290K | Hold |
598
| – | – | 0.12% | 114 |
|
|
2024
Q4 | $241K | Hold |
598
| – | – | 0.1% | 113 |
|
|
2024
Q3 | $278K | Hold |
598
| – | – | 0.12% | 110 |
|
|
2024
Q2 | $280K | Hold |
598
| – | – | 0.14% | 91 |
|
|
2024
Q1 | $250K | Hold |
598
| – | – | 0.13% | 104 |
|
|
2023
Q4 | $243K | Buy |
598
+300
| +101% | +$122K | 0.13% | 100 |
|
|
2023
Q3 | $104K | Buy |
298
+60
| +25% | +$20.9K | 0.06% | 148 |
|
|
2023
Q2 | $83.8K | Hold |
238
| – | – | 0.05% | 160 |
|
|
2023
Q1 | $75K | Buy |
238
+113
| +90% | +$35.6K | 0.04% | 181 |
|
|
2022
Q4 | $36.1K | Hold |
125
| – | – | 0.02% | 242 |
|
|
2022
Q3 | $36K | Sell |
125
-59
| -32% | -$17K | 0.02% | 236 |
|
|
2022
Q2 | $52K | Buy |
184
+59
| +47% | +$16.7K | 0.03% | 211 |
|
|
2022
Q1 | $33K | Buy |
125
+50
| +67% | +$13.2K | 0.02% | 234 |
|
|
2021
Q4 | $16K | Sell |
75
-25
| -25% | -$5.33K | 0.01% | 295 |
|
|
2021
Q3 | $18K | Hold |
100
| – | – | 0.01% | 267 |
|
|
2021
Q2 | $20K | Buy |
+100
| New | +$20K | 0.01% | 245 |
|